The Valley Desk

ArticleInflammatory bowel diseasesPublished

Efficacy, Safety, and Pharmacokinetics of Golimumab in Children with Moderately-To-Severely Active Ulcerative Colitis: Results from the PURSUIT 2 Study

Read the publication ↗ Open access copy ↗

Regional connection

Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source

Publication record

Type
Article
Venue
Inflammatory bowel diseases
Published
Subject terms
Humans; Colitis, Ulcerative; Antibodies, Monoclonal; Treatment Outcome; Remission Induction; Severity of Illness Index; Follow-Up Studies; Prospective Studies; Adolescent; Child; Child, Preschool; Female
PubMed ID
41503939
PubMed Central ID
PMC13234503
Open access
Yes, open
Added to directory
Source checked

Report a correction or request removal